<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(20)</volume><submitter>Foureau D</submitter><journal>Cancer medicine</journal><pagination>6933-6936</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8525140</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.</pubmed_title><pmcid>PMC8525140</pmcid><pubmed_authors>Foureau D</pubmed_authors><pubmed_authors>Bhutani M</pubmed_authors><pubmed_authors>Usmani SZ</pubmed_authors><pubmed_authors>Voorhees PM</pubmed_authors><pubmed_authors>Rigby K</pubmed_authors><pubmed_authors>Guo F</pubmed_authors><pubmed_authors>Tjaden E</pubmed_authors><pubmed_authors>Leonidas M</pubmed_authors><pubmed_authors>Paul B</pubmed_authors><pubmed_authors>Fox A</pubmed_authors><pubmed_authors>Atrash S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T22:43:23.163Z</modification><creation>2025-04-04T22:43:23.163Z</creation></dates><accession>S-EPMC8525140</accession><cross_references><pubmed>34494717</pubmed><doi>10.1002/cam4.4254</doi></cross_references></HashMap>